Last updated on March 2018

Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation


Brief description of study

The objective of this study is to evaluate the long-term safety and efficacy of linaclotide in post-marketing use.

Detailed Study Description

This is a post-marketing long-term specified drug use-result survey study required for products in Japan. The investigator will register the patient who have been taking this product for the first time within 14 days after the start of treatment (inclusive of the start day). For each of the registered patients (including withdrawals and dropouts), the investigator will enter the survey data on the case report form.

Clinical Study Identifier: NCT03471728

Contact Investigators or Research Sites near you

Start Over

Astellas Pharma Inc.

Site JP00003
Iwate, Japan
  Connect »